Moomoo AI 已提取核心訊息
On December 31, 2023, Sera Prognostics, Inc., a company specializing in high-risk pregnancy testing solutions, was the subject of a Schedule 13G filing with the United States Securities and Exchange Commission (SEC). The filing indicated that InterWest Partners X, LP (IWP X), along with its general partner InterWest Management Partners X, LLC (IMP X), and individual reporting persons Keval Desai, Gilbert H. Kliman, and Khaled A. Nasr, collectively reported ownership of 126,258 shares of Sera Prognostics' Class A Common Stock, which includes shares issuable upon the exercise of warrants. This represents approximately 0.4% of the company's Class A and B Common Stock, based on the number of shares outstanding as reported in the company's Form 10-Q filed on November 8, 2023. The filing was made under Rule 13d-1(c), indicating a passive investment position, and was signed on January 19, 2024, by Karen A. Wilson, Attorney-in-Fact for the reporting persons.
On December 31, 2023, Sera Prognostics, Inc., a company specializing in high-risk pregnancy testing solutions, was the subject of a Schedule 13G filing with the United States Securities and Exchange Commission (SEC). The filing indicated that InterWest Partners X, LP (IWP X), along with its general partner InterWest Management Partners X, LLC (IMP X), and individual reporting persons Keval Desai, Gilbert H. Kliman, and Khaled A. Nasr, collectively reported ownership of 126,258 shares of Sera Prognostics' Class A Common Stock, which includes shares issuable upon the exercise of warrants. This represents approximately 0.4% of the company's Class A and B Common Stock, based on the number of shares outstanding as reported in the company's Form 10-Q filed on November 8, 2023. The filing was made under Rule 13d-1(c), indicating a passive investment position, and was signed on January 19, 2024, by Karen A. Wilson, Attorney-in-Fact for the reporting persons.
2023年12月31日，專門從事高風險妊娠試驗解決方案的公司Sera Prognostics, Inc. 成爲向美國證券交易委員會 (SEC) 提交的附表13G文件的主體。文件顯示，InterWest Partners X, LP（IWP X）及其普通合夥人InterWest Management Partners X, LLC（IMP X）和個人申報人凱瓦爾·德賽、吉爾伯特·克里曼和哈立德·納斯爾共同報告了Sera Prognostics的126,258股A類普通股的所有權，其中包括行使認股權證時可發行的股份。根據該公司在2023年11月8日提交的10-Q表中報告的已發行股票數量，這約佔該公司A類和B類普通股的0.4％。該文件是根據第13d-1（c）條提交的，表明了被動投資頭寸，由申報人的事實律師凱倫·威爾遜於2024年1月19日簽署。
2023年12月31日，專門從事高風險妊娠試驗解決方案的公司Sera Prognostics, Inc. 成爲向美國證券交易委員會 (SEC) 提交的附表13G文件的主體。文件顯示，InterWest Partners X, LP（IWP X）及其普通合夥人InterWest Management Partners X, LLC（IMP X）和個人申報人凱瓦爾·德賽、吉爾伯特·克里曼和哈立德·納斯爾共同報告了Sera Prognostics的126,258股A類普通股的所有權，其中包括行使認股權證時可發行的股份。根據該公司在2023年11月8日提交的10-Q表中報告的已發行股票數量，這約佔該公司A類和B類普通股的0.4％。該文件是根據第13d-1（c）條提交的，表明了被動投資頭寸，由申報人的事實律師凱倫·威爾遜於2024年1月19日簽署。
有用
沒用